Despite strong guideline support, SGLT 2 inhibitors remain under utilize in elderly patients with heart failure, especially those greater than 80 years old. They are also under utilized in women. This large, real world, Medicare study highlights, persistent, disparities in prescribing patterns and calls for targeted interventions to improve equitable access to this life-saving therapy. #medicine #medical #doctor #doctors #sglt